In some cases, these symptoms are severe, making it difficult for patients to stick with the treatment
Heres the part I find most exciting, and the most underused in rheumatology right now
To view a copy of this licence, visit About this article Cite this article Modvig, I.M., Smits, M.M., Galsgaard, K.D
Participants received once-weekly subcutaneous injections of retatrutide at varying doses or placebo over 24 weeks, with a structured dose-escalation period built into the protocol to improve tolerability
It combines the biological support of GLP-1 medications with the habit-building tools that keep weight off long after the dose gets smaller
The findings build on growing evidence that the powerful drugs used to treat diabetes and obesity may have protective effects for the health of the brain as well